Hormone Therapy: a practical guide to risk assessment for short-term symptomatic treatment of menopausal symptoms

References

• Farnham AM. Uterine disease as a factor in the production of insanity. Alienst Neurologist 1887; 8:532
   Google Scholar
• Encyclopaedia Medica. Part 2. Edinburgh: William Green and Sons, 1899:297–302
   Google Scholar
• Guidozzi F. The Specialist Forum 2003; Oct:33–36
   Google Scholar
• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280(7):605–613.
   Google Scholar
• Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J et al. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen- progestin Replacement Study (HERS). Circulation 2001; 103(5):638–642.
   Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288(1):49–57.
   Google Scholar
• Burger H. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24–25, 2003. Climacteric 2003; 6 Suppl 1:11–36.
   Google Scholar
• Naftolin f, Schneider HPG, Sturdee DW. Guidelines for the hormonal treatment of women in the menopausal transition and beyond. Climacteric 2004;7:8–11
   Google Scholar
• Avis NE, Crawford SL, Mckinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997;3:103–120
   Google Scholar
• Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004; 11(1):11–33.
   Google Scholar
• Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995; 80(8):2354–2358.
   Google Scholar
• Freedman RR. Core body temperature variation in symptomatic and asymptomatic postmeno- pausal women: brief report. Menopause 2002; 9(6):399–401.
   Google Scholar
• Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmeno- pausal hot flushes? Acta Obstet Gynecol Scand 1990; 69(5):409–412.
   Google Scholar
• Randolph JF, Jr., Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88(4):1516–1522.
   Google Scholar
• Freedman RR, Woodward S, Brown B, Javaid JI, Pandey GN. Biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flashes. Menopause 1995;2:211–218
   Google Scholar
• Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001; 75(6):1065–1079.
   Google Scholar
• Markiewicz L, Gurpide E. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. J Steroid Biochem 1990; 35(5):535–541.
   Google Scholar
• Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Bio- chem Mol Biol 2001; 76(1–5):231–238.
   Google Scholar
• Hammar M, Christau S, Nathorst-Boos J, Rud T, Garre K. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998; 105(8):904–911.
   Google Scholar
• Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martinez de Osaba MJ, Casals E et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000; 34(2):161–168.
   Google Scholar
• Loprinzi CL, Kugler JW, Slaon JA et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized control trial. Lancet 2000;356:2059–2063
   Google Scholar
• Loprinzi CL, Sloan JA, Perez EA et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578–1583
   Google Scholar
• Beral V. Breast cancer and hormone- replacement therapy in the Million Women Study. Lancet 2003; 362(9382):419–427.
   Google Scholar
• Scarabin PY, Oger E, Plu-Bureau. Differential association of oral and transdermal oestrogen- replacement therapy with venous thromboembolism risk. Lancet 2003; 362(9382):428–432.
   Google Scholar
• Robinson D, Cardozo L. Urogenital effects of hormone therapy. Best Practice & Research Clinical Endocrinology & Metabolism 2003;17:91–104
   Google Scholar
• Mendoza N, Suarez AM, Alamo F, Bartual E, Vergara F, Herruzo A. Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17 beta-estradiol for hormonal replacement therapy in women with surgical menopause. Maturitas 2000; 37(1):37–43.
   Google Scholar
• Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS et al. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004; 11(1):57–61.
   Google Scholar
• Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349(6):523–534.
   Google Scholar
• Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A et al. Effect of estrogen plus progestin on stroke in post- menopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289(20):2673–2684.
   Google Scholar
• Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003; 289(24):3254–3263.
   Google Scholar
• Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 2001; 285(22):2891–2897.
   Google Scholar
• Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288(8):980–987.
   Google Scholar
• Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 2004; 11(1):49–56.
   Google Scholar